TAMPA, Fla., May 24, 2005 (PRIMEZONE) -- Rx Processing Corporation (Pink Sheets:RXPC), a provider of low-cost prescription medications and diagnostic lab testing solutions, announced today that the Company will be opening a new storefront location in Cape Canaveral, Fl. The name of the storefront location will be "Rx Direct" and will provide individuals with access to mail order prescription drugs and diagnostic tests at discount of up to 84% of retail prices.
Peter Fiorillo commented, "The new storefront operation in Cape Canaveral is a significant step forward since this location will be the first to distribute Maestro Debit Cards and MasterCards with all of the health advantages that are attached to the card. Individuals will be able to 'fill' their cards up to a specific spending capacity by paying cash and their card will be available for immediate use. We have no doubts that offering the Maestro Prepaid debit card as a Value-Added service to our discounted quality prescription drugs and diagnostic tests will provide a tremendous boost to our storefront operations.'
The Prepaid Maestro debit cards purchased at Rx Direct will give individuals the ability to get cash discounts on Prescription Drugs and Lab Tests with the value added services that include advances on their payroll of up to 50% of their weekly salary. Rx Processing Corp. has expanded its Prescription Drug operation center to handle the rapidly increasing client base due to the Company's recent agreement with FSI International to distribute the prepaid Maestro debit cards that also serve as Rx Processing member cards
About Rx Processing
Rx Processing is positioned to become a market leader in providing prescription drugs, lab tests and drug tests to U.S. Citizens, corporations, unions, and members through FDA-approved patient service centers for their Lab testing and licensed pharmacies in the United States and Canada. The Company provides access to approved brand name and generic medications as well as over 1,000 diagnostic tests through storefront locations with access to 6,000 FDA-approved patient service centers for their lab testing. Rx Processing estimates that more than 40 million Americans could benefit from the Company's low cost prescription drugs, lab testing and drug screening.
Safe Harbor Statement
All statements other than statements of historical fact included in this press release are "forward-looking statements." The forward-looking statements, including statements about the Company's future expectations, including future revenues and earnings, and all other forward-looking statements (i.e., future operational results and sales) are subject to assumptions and beliefs based on current information known to the Company and factors that are subject to uncertainties, risk and other influences, which are outside the Company's control, and may yield results differing materially from those anticipated.